108 research outputs found
Enhancing Respiratory Medication Adherence: The Role of Health Care Professionals and Cost-Effectiveness Considerations
Get PDFAdherence to medication comprises a multiphased temporal process involving (1) initiation of prescribed therapy, (2) implementation as prescribed, and (3) subsequent persistence. Medication adherence remains suboptimal in most patients with long-term respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Interventions have been shown to effectively improve treatment initiation, implementation, and persistence when delivered at the health care professional level or the system level, but demonstration of the cost-effectiveness of these interventions is necessary to ensure their widespread use. This review summarizes how health care professionals can intervene to improve medication adherence in patients with asthma and COPD, provides some examples of effective primary care interventions, and illustrates some of the challenges to optimal implementation arising from cost-effectiveness modeling. Improving adherence is shown to be an economically viable treatment option for patients with asthma and COPD, but there are differences in the health economics pertaining to each condition and setting that can affect whether an intervention is considered cost-effective. Targeting adherence interventions at patients with the greatest to gain, and tailoring them to individual patient needs, may help to optimize cost-effectiveness ratios and improve the probability of positive reimbursement decisions, systemwide implementation, and resultant health benefits
‘Frisse’ berglucht toch niet altijd gezond?
Get PDFEerdere onderzoeken naar de relatie tussen hoogte en COPD trokken tegenstrijdige conclusies. Een van de belangrijkste risicofactoren voor COPD wereldwijd namen ze daarbij echter vrijwel niet mee: fijnstof binnenshuis. Daarom vergeleken wij fijnstofconcentraties en COPD-prevalentie binnenshuis tussen hooglanden en laaglanden in Kirgistan. Zowel fijnstof als COPD kwam alarmerend veel voor in de hooglanden. Maar ook in onze lage landen kunnen de fijnstofconcentraties binnenshuis oplopen tot ver boven de aanbevolen waarden, bijvoorbeeld tijdens het koken en openhaardgebruik
Costly comorbidities of COPD: The ignored side of the coin?
Get PDFComorbidities more costly than COPD itself: multimorbidity requires change in healthcare practice and financing
Digital adherence interventions for asthma
No full textDigital technologies are increasingly used to support asthma management and improve medication adherence. Evidence shows that digital adherence interventions can have important benefits on medication adherence and outcomes. While there remain some uncertainties about how best to implement digital interventions into everyday practice and whether digital interventions are cost-effective and acceptable to end users, digital interventions are likely to bring significant benefits for patients, health professionals and society. Interventions include digital inhalers and spacers, self-management apps, web interventions, telehealth and text message services. Interventions vary in functionality, maturity of the technology, and the amount of evidence supporting their use. Careful selection of the digital intervention that is best suited for the patient's asthma needs, lifestyle, abilities and preferences is important to ensure successful implementation. Ongoing evaluation of the rapidly evolving technology and long-term benefits they bring is needed to support sustained adoption and engagement. Further research into the added value of digital adherence interventions in practice is needed
Socio-economic costs of asthma
Get PDFGLOBAL ATLAS OF ASTHMASECTION A- Asthma - definition, epidemiology and risk factorsSocio-economic costs of asthma• The economic burden of asthma, consisting of direct and indirect costs, is substantial• Major direct costs include medication, outpatient visits, and hospital admissions• Major indirect costs include work productivity losses, missing school, and caregiver burden• Cost enhancing factors include severe, uncontrolled asthma, and comorbidities• There are large global differences in the socioeconomic burden of asthm
Socio-economic costs of asthma
No full textGLOBAL ATLAS OF ASTHMASECTION A- Asthma - definition, epidemiology and risk factorsSocio-economic costs of asthma• The economic burden of asthma, consisting of direct and indirect costs, is substantial• Major direct costs include medication, outpatient visits, and hospital admissions• Major indirect costs include work productivity losses, missing school, and caregiver burden• Cost enhancing factors include severe, uncontrolled asthma, and comorbidities• There are large global differences in the socioeconomic burden of asthm
Socio-economic costs of asthma
Get PDFGLOBAL ATLAS OF ASTHMASECTION A- Asthma - definition, epidemiology and risk factorsSocio-economic costs of asthma• The economic burden of asthma, consisting of direct and indirect costs, is substantial• Major direct costs include medication, outpatient visits, and hospital admissions• Major indirect costs include work productivity losses, missing school, and caregiver burden• Cost enhancing factors include severe, uncontrolled asthma, and comorbidities• There are large global differences in the socioeconomic burden of asthm
- …
